Fertile females with nonalcoholic fatty liver disease (NAFLD) have higher levels of ALT than postmenopausal females: Implications for the influence of fertility on NAFLD

Hepato-Gastroenterology

Volumn 54, Issue 73, 2007, Pages 224-228

  Kotoh, Kazuhiro ^a   Nakamuta, Makoto ^a   Fukushima, Marie ^a   Morizono, Shusuke ^a   Enjoji, Munechika ^a   Nawata, Hajime ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Estrogen; Fertility; Insulin resistance; Nonalcoholic fatty liver disease (NAFLD); Nonalcoholic steatohepatitis (NASH); Postmenopause; Sex steroids

Indexed keywords

ALANINE AMINOTRANSFERASE; C PEPTIDE; INSULIN;

ADOLESCENT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ECHOGRAPHY; FATTY LIVER; FEMALE; FEMALE FERTILITY; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; POSTMENOPAUSE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; ALANINE TRANSAMINASE; C-PEPTIDE; DISEASE PROGRESSION; ESTROGENS; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED;

EID: 34047103320     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Mehta K, Van Thiel DH, Shah N, Mobarhan SL: Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr Rev 2002; 60:289-293.
2. Harrison SA, Di Bisceglie AM: Advances in the understanding and treatment of nonalcoholic fatty liver disease. Drugs 2003; 63:2379-2394.
3. Day CP: Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol 2002; 16:663-678.
4. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al: Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37:917-923.
5. Deschamps D, De Beco V, Fisch C, Fromentry B, Guillouzo A, Pessayre D: Inhibition by perhexiline of oxidative phosphorylation and the β-oxidation of fatty acids: possible role in pseudoalcoholic liver disease. Hepatology 1994; 19:948-961.
6. Pérez-Carreras M, Del Hoyo P, Martin MA, Rubio JC, Martin A, Castellano G, et al: Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 2003; 38:999-1007.
7. Chalasarni N, Gorski C, Asghar MS, Asghar A, Foresman B, Hall SD, Crabb W: Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis. Hepatology 2003; 37:544-550.
8. Lieber CS: CYP2E1: from ASH to NASH. Hepatol Res 2004; 28:1-11.
9. Harrison SA, Torgerson S, Hayashi PH: The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. Am J Gastroenterol 2003; 98:2042-2047.
10. Angulo P, Keach JC, Batts KP, Lindor KD: Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30:1356-1362.
11. Kashireddy PR, Rao MS: Sex differences in choline-deficient diet-induced steatohepatitis in mice. Exp Biol Med (Maywood) 2004; 229:158-162.
12. Fujimoto N, Kohta R, Kitamura S, Honda H: Estrogenic activity of an antioxidant, nordihydroguaiaretic acid (NDGA). Life Sci 2004; 74:1417-1425.
13. Perez-Carreras M, Del Hoyo P, Martin MA, Rubio JC, Martin A, Castellano G, Colina F, et al: Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 2003; 38:999-1007.
14. Luyckx FH, Lefebvre PJ, Scheen AJ: Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab 2000; 26:98-106.
15. Xu JW, Gong J, Chang XM, Luo JY, Dong L, Hao ZM, Jia A, et al: Estrogen reduces CCL4- induced liver fibrosis in rats. World J Gastroenterol 2002; 8:883-887.
16. Starkel P, Sempoux C, Leclercq I, Herin M, Deby C, Desager JP, Horsmans Y: Oxidative stress, KLF6 and transforming growth factor-beta up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. J Hepatol 2003; 39:538-546.
17. Shimizu I: Impact of oestrogens on the progression of liver disease. Liver Int 2003; 23:63-69.
18. Robertson G, Leclercq I, Farrell GC: Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol 2001; 281:G1135-1139.
19. Stork S, von Schacky C, Angerer P: The effect of 17beta-estradiol on endothelial and inflammatory markers in postmenopausal women: a randomized, controlled trial. Atherosclerosis 2002; 165:301-307.
20. O'Sullivan AJ, Martin A, Brown MA: Efficient fat storage in premenoposal women and in earuly pregnancy: a role for estrogen. J Clin Endocrinol Metab 2001; 86:4951-4956.
21. O'Sullivan AJ, Crampton LJ, Fruend J, Ho KKY: The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women. J Clin Invest 1998; 102:1035-1040.
22. Kishimoto R, Ogishi Y, Ueda M, Matsusaki M, Amano K, Goda K, Park SS: Gender-related difference in mouse hepatic ethanol metabolism. J Nutr Sci Vitaminol 2002; 48:216-224.
23. Jarvelainen HA, Lukkari TA, Heinaro S, Sipple H, Lindros KO: The antiestrogen toremifene protects against alcoholic liver injury in female rats. J Hepatol 2001; 35:46-52.
24. Jalouli M, Carisson L, Ameen C, Linden D, Ljungberg A, Michalik L, et al: Sex difference in hepatic peroxisome proliferator-activated receptor alpha expression: influence of pituitary and gonadal hormones. Endocrinology 2003; 144:101-109.